Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is currently treated with a daily combination of rifampin and either injectable streptomycin or oral clarithromycin. An intermittent oral regimen would facilitate treatment supervision. We first evaluated the bactericidal activity of newer antimic...
Saved in:
Main Authors: | Chauffour, Aurélie, Robert, Jérôme, Veziris, Nicolas, Aubry, Alexandra, Pethe, Kevin, Jarlier, Vincent |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/148764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish
by: Dupont, Christian, et al.
Published: (2018) -
MECHANISM OF ACTION OF THE ANTI-TUBERCULOSIS DRUG CANDIDATE TBAJ-876
by: JICKKY PALMAE SARATHY
Published: (2020) -
BEDAQUILINE TARGETS THE EPSILON SUBUNIT OF MYCOBACTERIAL F-ATP SYNTHASE
by: SUBHASHRI KUNDU
Published: (2017) -
Sensitivity of mycobacterium leprae to telacebec
by: Lahiri, Ramanuj, et al.
Published: (2022) -
Telacebec : an investigational antibacterial for the treatment of tuberculosis (TB)
by: Lee, Bei Shi, et al.
Published: (2022)